New Zealand funds off-label cystic fibrosis treatment
This article was originally published in Scrip
Executive Summary
Cystic fibrosis patients in New Zealand will be able to use the antibiotic azithromycin, after the pharmaceutical management agency Pharmac widened its funded access on July 1st.